# Efficacy and Safety of Ascending Dosages of Moxidectin and Moxidectin-albendazole Against Trichuris Trichiura

> **NCT03501251** · PHASE2 · COMPLETED · sponsor: **Swiss Tropical & Public Health Institute** · enrollment: 286 (actual)

## Conditions studied

- Trichuris Trichiura; Infection

## Interventions

- **DRUG:** Moxidectin 8mg
- **DRUG:** Moxidectin 8 mg + albendazole 400 mg
- **DRUG:** Moxidectin 16 mg
- **DRUG:** Moxidectin 16 mg + albendazole 400 mg
- **DRUG:** Moxidectin 24 mg
- **DRUG:** Moxidectin 24 mg + albendazole 400 mg
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03501251
- **Lead sponsor:** Swiss Tropical & Public Health Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-03
- **Primary completion:** 2018-08-11
- **Final completion:** 2018-08-11
- **Target enrollment:** 286 (ACTUAL)
- **Last updated:** 2018-08-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03501251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03501251, "Efficacy and Safety of Ascending Dosages of Moxidectin and Moxidectin-albendazole Against Trichuris Trichiura". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03501251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*